戻る
「早戻しボタン」を押すと検索画面に戻ります。

今後説明を表示しない

[OK]

コーパス検索結果 (1語後でソート)

通し番号をクリックするとPubMedの該当ページを表示します
1 oster care and the need for such programs to continue.
2  in 2015, but its use in other countries may continue.
3 patients with PIDs, and advances are sure to continue.
4 s that generate and maintain biodiversity to continue.
5 as their concentrations decreased as storage continued.
6 mg), and tenofovir alafenamide (25 mg) or to continue a single-tablet regimen of efavirenz (600 mg),
7 ricitabine, and tenofovir alafenamide versus continuing a regimen of boosted protease inhibitor, emtr
8 e immune response with or without the driver continues, a cascade of events can trigger immunological
9 ong-lasting recovery of movement despite the continued absence of dopamine.
10 ile X Syndrome (FX) can be attributed to the continued absence of FMRP from the PFC, independent of F
11 ed in 365 patients (96 initial registry, 269 continued access patients).
12  from the initial registry to the subsequent continued access registry, both at 30 days (8.2% vs. 0.7
13 ome adaptations in the hand that facilitated continued access to forest canopy may have complemented,
14                                              Continued advancements in sequencing technologies have f
15 pediatric patient's family requested care be continued after declaration of death by neurologic crite
16                   While forest loss and fire continued after RSPO certification, certified palm oil w
17 te species indicates that mesoderm induction continues after gastrulation in neuromesodermal progenit
18 ved after the initial decline from peak with continued agonist exposure.
19  the use and distribution of ENM in products continues along current trends (i.e., a business-as-usua
20                                       Debate continues among clinicians as to both the clinical relev
21 ailable software tool was developed to allow continued analyses of these and other transcriptional pr
22                              As disturbances continue and species shifts persist, the future of these
23 provides the immunological evidence base for continuing annual influenza vaccination in adults.
24 r results imply a dynamic EAIS response with continued anthropogenic warming and suggest that the EAI
25 lizumab after long-term treatment results in continued benefit, as evidenced by improved symptom cont
26 he absence of progression, patients in arm B continued bevacizumab alone until disease progression or
27 mice enabling longitudinal TFAR profiling by continued bioimaging throughout the lives of the animals
28 etween 20% and 36% of the adverse effects of continued cannabis use on outcome in psychosis might be
29 d two hypotheses: either other aspects of V1 continue changing, or later changes in visual perception
30 a viruses represent a pandemic threat due to continued circulation in wild birds and limited immunity
31 ensify tOPV use prior to OPV2 cessation show continued circulation of serotype 2 vaccine-derived poli
32 ot having sex on first meeting, while living/continued communication with sexual partner(s) was assoc
33 n lives, and save $3.2 billion compared with continuing Constant Effort up to 2050.
34 ay) was injected 3 hours post-MI for (d)1 or continued daily till d5.
35 ntiated effector cells and renews itself for continued defense.
36  barriers need to be addressed to ensure the continued development of future surgeon-scientists.
37 nts, and molecular catalysts, motivating the continuing development of efficient, selective, and sust
38       In this Progress Article, we highlight continuing developments and identify future opportunitie
39 he expression of adipogenic target genes and continued differentiation.
40 NA unwinding by the replicative helicase may continue during such pauses, but a self-governing mechan
41                       Allergen challenge was continued during HOCl hydrogel application.
42  were fed for 3 weeks prior to infection and continuing during infection and recovery one of the foll
43 or STEM careers threatens the United States' continued economic progress.
44 ines for this disease offers a framework for continued enhancement of the outcome for patients.
45 arcinoma cancers are encouraging and support continued evaluation of anti-EGFR antibodies in this sub
46                             However, mitosis continues even when kinetochore fibers are not obviously
47  we show that cargo processing and transport continue-even when individual Golgi cisternae are separa
48                                            A continued excess mortality occurred after perforation, w
49                                              Continued expansion in the size and dimensionality of ca
50                                          The continued expansion of the fields of macromolecular chem
51        Missing a diagnosis of OA may lead to continued exposure to a causative agent and progressive
52      Using this model, they demonstrate that continued expression of oncogenic K-RAS is required for
53                    Since then, alongside the continued extraction of data from the medicinal chemistr
54 rden of elevated BMI highlights the need for continued focus on surveillance of BMI and identificatio
55 n the protein reach the transition state and continue folding.
56                                              Continued follow-up is warranted.
57 ia, and Nigeria) and proposes that resources continue for long-term maintenance in resource-poor coun
58 ays 5 to 14 to high-risk preterm infants and continued for 24 days, appears to be safe but did not im
59 s at higher dosages; (3) treatment should be continued for 6-12 months to potentially prevent relapse
60 c plugged catheter, antibiotic treatment was continued for 7 days.
61                                Treatment was continued for as long as the patients derived clinical b
62 oping age-related macular degeneration (AMD) continued for people born during the Baby Boom years (19
63           Genetic diversity is maintained by continuing generation and removal of variants.
64  by foot-shock stress, but in the absence of continued global elevations in H3K9me2.
65 e, in order to obtain nutrients required for continued growth and proliferation.
66                                         With continued high rates of adult obesity and DM along with
67    Future policy interventions are needed to continue improvement in dietary quality and to address d
68                                              Continued improvement to 36-months postinjury was only p
69 onin-norepinephrine reuptake inhibitors were continued in ICU, complicating interpretation.
70 se has changed dramatically, which has to be continued in the future.
71 endations for halting and then reversing the continuing increases in this burden.
72                                              Continued input of observations into FRED to fill gaps i
73                 Such measures, together with continued international efforts in education and trainin
74 cooling that started well before the EOT and continued into the Early Oligocene.
75 rience's impact on this neural balancing act continues into adulthood [3-5].
76    However, our findings provide a basis for continued investigation of BIIB074 in patients with trig
77 e is sufficiently strong evidence to support continued investigation of the potential benefits of hel
78 is review, we provide a rationale to support continued investment in Cryptococcus vaccine research, p
79 scussions for the expanded use of RTS,S/AS01 continue, it will be critical to determine the performan
80 ely limit the ability of plastic surgeons to continue its use in this clinical context.
81                                          The continued kidney allograft shortage has generated intere
82 ce that if the decline in primary production continues, knock-on effects upon the productivity of fis
83 ts, represent one important research tool to continue making progress in this field.
84 bsite using a computer-generated sequence to continue MDI or switch to CSII, with continuation of CGM
85 avior and quality of life than did those who continued medical therapy alone at 12 months.
86 -being will increasingly be based on health, continued mental stimulation, and consumption of cultura
87 p lifestyle sessions to all participants and continued metformin in the originally randomized metform
88 ges in MATS coverage underscore the need for continued monitoring of antigen expression and diversity
89  occurs in approximately 20%, indicating the continued need for more effective and less toxic therapi
90  current understanding of AD in ACD, and the continued need to investigate the interplay between thes
91 ming again well behaved and the computations continuing normally.
92                                          The continued observation of heterogeneity of treatment resp
93 along both mapped and unmapped faults before continuing offshore at the island's northeastern extent.
94                       If tolerated, subjects continued on 4000 mg of peanut protein daily.
95                        At 12 weeks, patients continued on anakinra showed an improvement in peak Vo2
96 ified AHC or ovalbumin on alternate days and continued on HFD for another 10 weeks.
97 d agents, patients progressing with CLL were continued on ibrutinib for up to 3 months, with 19.8 mon
98 tching rules were met, although all patients continued on their originally assigned treatment.
99 -threatening form of status epilepticus that continues or recurs despite 24 hours or more of anesthet
100 efit and persistence of response in subjects continuing or withdrawing from long-term omalizumab trea
101            With an aging ESRD population and continued organ shortage, preservation of average post-t
102 the replication stress checkpoint, promoting continued origin firing.
103 ith the basement membrane, but contribute to continued outgrowth through increased cell size.
104                                   As debates continue over the functional significance of many specif
105 ration was predicted to be more effective if continued over 2 years rather than 1 year, and if done a
106 success achieved in managing these patients, continued participation in available clinical trials in
107 ained inhibition of Ca(2+) transients in the continued presence of agonist, indicating the activation
108 ity of cholinergic SK responses requires the continued presence of extracellular calcium.
109 break strain SPH2015 from Brazil resulted in continued protection against infection, no viral sheddin
110  level of systemic resilience and aiding its continued recovery.
111                                              Continued refinement to the model to reflect diverse bio
112      Progressively separated pObs pools then continue regenerating independently to collectively re-f
113 n this review we will provide an overview of continuing relevant research and highlight different app
114 g those made in recent decades, will require continued research into mechanisms underlying disease pr
115                                              Continued research on CRF mutations will be critical for
116                       It is anticipated that continued research will lead to a more comprehensive und
117                                          The continuing research challenge is to improve prediction o
118 /VT cardiac arrest who also met criteria for continuing resuscitation in the CCL.
119 ned to continue risperidone for 32 weeks, to continue risperidone for 16 weeks followed by switch to
120  responded (N=110) were randomly assigned to continue risperidone for 32 weeks, to continue risperido
121 indicative of elevated rigidity; yet despite continued ROCK2 activities/p-Mypt1 inactivation, progres
122 ls and hyperpolarization, but in response to continued signaling MORs undergo acute desensitization r
123                                              Continued strengthening of referral systems from HEWs an
124      Our results emphasize the importance of continuing surveillance of sexual behaviors, alongside v
125 to switch to the open-label study regimen or continue the control regimen.
126 agulant agents, and new coronary stents will continue the journey to achieve this ultimate goal.
127 latory bodies supporting great innovators to continue the philosophy of thinking beyond the limits th
128  clopidogrel had (compared with patients who continued the study medications) a lower risk of major c
129 antiretroviral treatment (ART) randomized to continue (the CTX arm) or discontinue (the STOP-CTX arm)
130 supplementary immunization activities (SIAs) continued, the targeting of settlements at high risk for
131 ur search for an efficacious malaria vaccine continues, the development of a whole-organism vaccine i
132 f marijuana for medical and recreational use continues, the effects of increased use and potency of m
133 crease body fat gain compared with girls who continued their low calcium intake.
134 on an aspirin regimen and were randomized to continued thienopyridine therapy vs placebo for 18 addit
135 merging pandemic influenza viruses present a continued threat to global public health.
136 0 mg twice daily) was started on day -10 and continued through day +100 post-HCT.
137                                 Surveillance continued through December 5, 2016.
138 assive quantities of diverse omics data that continue to accumulate rapidly.
139 otherapy and ongoing randomised studies will continue to aim to optimise treatment for high-risk neur
140 bed appropriately to treat infections, there continue to be a large number of inappropriately prescri
141 c hyperplasia and bladder outlet obstruction continue to be a serious health problem.
142                            As new strategies continue to be developed, it is equally important to con
143  signaling pathways involved in pathogenesis continue to be discovered.
144 chanistic aspects of Fe/S protein biogenesis continue to be elucidated by biochemical and ultrastruct
145            Perinatal mortality and morbidity continue to be major global health challenges strongly a
146                                        Women continue to be more likely to practice in academic cente
147         This survey revealed that skin tests continue to be the main diagnostic procedure and are use
148                 As laser cooling experiments continue to bring massive mechanical systems to unpreced
149 c interventions, resistant fungal infections continue to cause significant morbidity and mortality in
150 s stabilize in cortical association areas or continue to change following learning.
151                      However, the field must continue to characterize the specific role pro-inflammat
152 thogenic avian influenza (HPAI) H5N1 viruses continue to circulate in nature and threaten public heal
153 ids, instead of arresting in G1, these cells continue to cycle and utilize lipid droplets as a source
154            Advances in sequencing technology continue to deliver increasingly large molecular sequenc
155 ompliance with these effective drugs, and to continue to develop new drugs that do not cause these si
156 lp to conceive, plan, and develop the study; continue to direct the day-to-day conduct of the study;
157  in industrial automation, and will probably continue to do so for decades to come.
158 ted ERG in prostate cancer and other cancers continue to enhance its role in cancer biology and its u
159 on currently underway or on the horizon will continue to evolve and expand the footprint of telemedic
160 passage indicates that influenza viruses can continue to evolve in galliform species, increasing thei
161 Finally a perspective on how this field will continue to evolve is provided.
162 lity as donation and transplantation systems continue to evolve.
163                                        As we continue to examine the mechanisms by which miRNAs maint
164 he rate of entry into pediatric surgery will continue to exceed population growth through 2030 under
165 nents that are no longer necessary but might continue to exert their effects on recipient cells.
166 ght technological developments in 2D IR that continue to expand the scope of scientific problems that
167                  Consistent with this, mTECs continue to express Fezf2 and Aire, regulators of intrat
168                  It is possible that RPE may continue to form a preserved photoreceptor-RPE complex t
169 pparent turnover frequency of 440 s(-1), and continue to generate additional initiators throughout th
170 s in chemical analysis and genome sequencing continue to greatly advance our understanding of this bi
171 how, for the first time, that dopamine axons continue to grow from the striatum to the PFC during ado
172                            The crystals then continue to grow to develop morphologies characteristic
173                         Implantation volumes continue to grow, but several challenges remain to be ov
174  with low input requirements, is expected to continue to have an important role in supplying food and
175                 However, HIV-positive blacks continue to have much higher rates of ESRD than HIV-posi
176 he lack of robust analytical techniques that continue to hinder the purification and characterization
177 The National Institutes of Health (NIH) will continue to improve the Browser in response to user feed
178  that short- and long-term clinical outcomes continue to improve.
179 n the past several decades and are likely to continue to increase in the future under the influence o
180 ses in (15)N enrichment in the shells, which continue to increase in value up to the modern shell val
181         Despite a large body of research, we continue to lack a detailed account of how auditory proc
182   Variability in eye growth and myopic shift continue to make refractive outcomes challenging for IOL
183 sistance in An. funestus, it is necessary to continue to monitor the contribution of the mutations de
184 les vaccination campaigns, measles outbreaks continue to occur regularly in Nigeria, leading to high
185 hnological implications, as biosonar systems continue to outperform man-made sonar systems in noisy,
186                        Organ donor shortages continue to persist, especially in regions of the United
187  along with other emerging influenza viruses continue to pose pandemic threats.
188  in low- and middle-income countries need to continue to prepare themselves to prevent additional hea
189 sis for a large number of genodermatoses and continue to provide a unique perspective on and insight
190 horts in diverse environments worldwide will continue to provide critical knowledge about the factors
191  into this interesting set of compounds will continue to provide insights into fundamental questions
192 Further exploration of the target genes will continue to provide new insights into the etiology of lu
193 on and next-generation sequencing approaches continue to provide promising new hints to answer these
194  to IEs were better maintained and these may continue to provide some protection.
195 ts with a proven indication for a PPI should continue to receive it in the lowest effective dose.
196 of the either the mother or fetus, providers continue to recommend the women with HIV avoid pregnancy
197  to be developed, it is equally important to continue to refine our understanding and interpretation
198                                   Thus, dogs continue to represent an important reservoir for zoonoti
199 y contrast, complex congenital heart defects continue to require open-heart surgery.
200  link with FMRP loss >;25 years ago, studies continue to reveal diverse FMRP functions.
201 ore widespread relative to N as temperatures continue to rise.
202 thods evolve, these new systems of care must continue to serve the needs of children.
203 strumentation, and data processing platforms continue to spur growth in the lipidomics field, more st
204 plasmic fragments that lack genomic DNA, but continue to synthesize protein using a pool of messenger
205              Opportunistic fungal infections continue to take an unacceptably heavy toll on the most
206 eeding from NSAIDs should take a PPI if they continue to take NSAIDs.
207 dent, and thus plants without stomata should continue to take up COS in the dark.
208                        The mesoporous shells continued to act as regulators restricting the release o
209              Ferroelectric domain walls have continued to attract widespread attention due to both th
210 w-density lipoprotein level, statin exposure continued to be associated with a reduction in OAG risk.
211                                     Benefits continued to be observed with longer-term treatment, and
212 on, institutional support, and collaborators continued to be positive influential factors.
213  of tacrolimus trough levels <5 ng/ml, which continued to be significant after adjustment for HLA-DR/
214               Allergy and atopic asthma have continued to become more prevalent in modern society des
215 ward the low intensity of the sated odor but continued to choose the high intensity of the nonsated o
216 t decrease significantly after the tear, but continued to decline compared with control eyes at all e
217 avenous chemotherapy agents had overuse that continued to decrease 6 months after the CW.
218 e and SCD animals during infection, SCD mice continued to deteriorate and failed to resolve the infec
219                 In contrast, NE-treated rats continued to display accurate memory of the shock-contex
220 tered to half the patients, and all patients continued to exercise for 2 minutes at the same workload
221           However, only double-knockout mice continued to exhibit low liver Hamp at 8 weeks and faile
222 81 participants (29.5%; 95% CI, 25.9%-33.1%) continued to exhibit no clinical or laboratory evidence
223 or a single "early burst" model, morphospace continued to expand following a slowdown in rates.
224  feeder visits became fixed early while bees continued to experiment with the order of later visits.
225 amics and the presence and abundance of mice continued to fluctuate with human mobility through the t
226                           Animals in group 1 continued to have weight gain and biochemical analyses c
227                      As thaw in Soil warming continued to increase linearly, ground surface subsidenc
228                           We showed that ASM continued to mature until approximately 3 wk after birth
229 ns in the years 2015-2016 but sporadic cases continued to occur.
230                              The formed gaps continued to propagate after composite light curing fini
231 terim analyses of KEYNOTE-006, pembrolizumab continued to provide superior overall survival versus ip
232          Among the remaining 49 patients, 16 continued to receive antibiotics, usually for infections
233 atients initially randomized to cyclosporine continued to receive cyclosporine-based immunosuppressio
234     The chemotherapy plus bevacizumab groups continued to show significant improvement in OS compared
235 f Maine, white pine needle damage (WPND) has continued to spread and is now well established in all N
236 ximal and distal limb enhancers nevertheless continued to work independently over a targeted transgen
237      Acute graft-versus-host disease (aGVHD) continues to be a frequent and devastating complication
238                         Exposure to violence continues to be a growing epidemic, particularly among c
239 eviously unavailable shapes and compositions continues to be a key need and interest in nanotechnolog
240                Invasive pneumococcal disease continues to be a major cause of morbidity and mortality
241 nded DNA (dsDNA) without sequence-preference continues to be a major challenge.
242           The economic cleanup of wastewater continues to be an active area of research.
243 t atmosphere and the solar wind acceleration continues to be an outstanding problem in solar-astrophy
244  recognized, their exact function in the CNS continues to be explored.
245 otein trans-activator of transcription (Tat) continues to be expressed in virally suppressed patients
246 ardiovascular health of postmenopausal women continues to be of public health interest.This report ev
247 lity of radiation dose according to facility continues to be wide.
248                   Mycobacterium tuberculosis continues to cause devastating levels of mortality due t
249               Seasonal human influenza virus continues to cause morbidity and mortality annually, and
250 plications of chalcogen-bonding interactions continues to develop, debate still surrounds the energet
251 le and aggregated brain amyloid-beta (Abeta) continues to dominate clinical research in AD, a deeper
252                                          MGD continues to enhance access to these data, to extend the
253 gely unchanged, understanding of the disease continues to evolve.
254              If the base-level Spillway Lake continues to expand to a fully formed moraine-dammed gla
255 bal market, yet most research and regulation continues to focus on a limited selection of rather well
256 s the body of research concerning metastasis continues to grow at a rapid rate, the biological progra
257                     Poor delivery efficiency continues to hamper the effectiveness of cancer therapeu
258                                     Research continues to identify novel therapies, in particular eff
259 sable elements (TEs), whose ongoing activity continues to impact our genome.
260                             The HIV pandemic continues to impose enormous morbidity, mortality, and e
261 cant health burden in western countries, and continues to increase in prevalence.
262  use of nanopesticides in modern agriculture continues to increase, their effects on crop plants are
263  mortality, whereas the overall burden of HF continues to increase.
264 curity outside the contexts of official wars continues to plague many parts of the world.
265                                       Sepsis continues to present a major burden to U.S. emergency de
266                                       Rabies continues to present a public health threat in most coun
267 y removal and conventional immunosuppression continues to provide excellent patient and graft surviva
268                                          AMD continues to remain a significant public health problem
269 atients awaiting solid organ transplantation continues to remain much higher than the number of organ
270 , the total number of children with stunting continues to rise in sub-Saharan Africa.
271 population worldwide, the incidence of falls continues to rise.
272              Moreover, developmental biology continues to roll on, budding off more disciplines, whil
273 e goal of creating a more powerful tool that continues to serve the existing community while addressi
274 rature [Formula: see text] or whether motion continues to slow gradually down to zero temperature.
275 th exposure to repetitive brain trauma (RBT) continues to strengthen.
276                             Current evidence continues to support the benefits of an earlier rather t
277                             Current evidence continues to support the use of selective serotonin reup
278                                              Continuing to overlook the vast majority of other PFASs
279                        Here, we analyzed the continued trajectory of these measures out to 2 years an
280  mobile DNAs are self-propagating, and their continued transposition is a source of both heritable st
281 tions during the previous 12 months, despite continued treatment.
282 ised pulmonary exacerbation rate in patients continuing treatment through extension week 96 (0.65, 0.
283                                 For patients continuing treatment, the mean change from baseline in p
284 l focus (38%); 87% of respondents planned to continue TSMB.
285 s an asthenospheric drag force, which drives continued underthrusting of the Indian continental litho
286 d with vaccinia virus, but mass fluctuations continue until cell death.
287  any specimen at week 4, biweekly collection continued until all specimens tested negative.
288 e treatment with bevacizumab monotherapy was continued until progressive disease without significant
289           This intermittent sunitinib dosing continued until Response Evaluation Criteria in Solid Tu
290 c in association with global glaciations and continued until the end of the Lomagundi carbon isotope
291 , membranes heal spontaneously and pregnancy continues until term.
292 oreactive LEP following exposure to hypoxia, continuing upon return to normoxia.
293 ty building, to ensure acceptance of IPV and continued uptake of OPV.
294 nd 4.3 (2.9-7.6) per 100 000 population with continued use of longer therapy-ie, the short-course reg
295 ICU patients resulting from chronic effects, continued use, or withdrawal.
296                   We allowed participants to continue using any concomitant disease-modifying antirhe
297  photochemical products in the dark or under continued UV irradiation both resulted in nucleation and
298 erwent HCT, starting pre-transplantation and continuing weekly until 100 days post-transplant, a tota
299 of 252 patients, the protocol was amended to continue with a three-arm design (1:1:6 ratio), with a n
300 ssuring that oral PrEP delivery to women can continue without the need for concurrent testing for bac

WebLSDに未収録の専門用語(用法)は "新規対訳" から投稿できます。
 
Page Top